2026年5月15日 / 美国东部时间晚上10:11 / 哥伦比亚广播公司新闻
美国食品药品监督管理局（FDA）负责监管处方药和非处方药部门的负责人即将离任，一名FDA高级官员向哥伦比亚广播公司新闻证实了这一消息，这标志着FDA高层又一次重大人事震荡。
特雷西·贝丝·赫格博士自去年12月起担任FDA药品评价与研究中心（CDER）代理主任，领导该机构审查新药申请。她此前曾担任FDA前局长马蒂·马卡里博士的顾问。
美国卫生与公众服务部发言人未立即回应置评请求。赫格离职的消息最先由路透社报道。
赫格离职的三天前，马卡里因大量关于FDA内部紧张局势的新闻报道辞职，其中包括近期批准调味电子烟的分歧。一位知情人士向哥伦比亚广播公司新闻透露，马卡里离职是因为电子烟争议，他本人并不批准调味产品，但被迫迫于政府其他成员的压力签署了批准令。
FDA负责疫苗审批办公室前主任维奈·普拉萨德博士也于上月离职。普拉萨德曾在去年夏天短暂离职，但不到两周后就官复原职。
哥伦比亚广播公司新闻此前曾报道，赫格被任命为CDER负责人一事引发了争议，并令FDA高级官员感到警觉，原因是她曾有过质疑疫苗的历史。她曾在去年撰写一份备忘录，称多起儿童死亡事件与新冠疫苗有关，但未提供证据支持这一说法，她还参与了一项颇具争议的削减推荐儿童疫苗种类的行动。
“让特雷西·贝丝执掌大权无异于投下一颗原子弹，”一位FDA内部人士去年12月对哥伦比亚广播公司新闻表示。
blob:https://www.cbsnews.com/4085a5d9-bf0d-4a09-b853-318753a92596
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
赫格曾承认部分疫苗的有效性，包括麻疹疫苗。她在确认任职时表示，她“致力于透明、诚实，基于严谨的科学做出决策，并确保重要改革高效推进”。
Controversial FDA official leaving drug center post in latest departure at agency
May 15, 2026 / 10:11 PM EDT / CBS News
The leader of the Food and Drug Administration division responsible for regulating prescription and over-the-counter drugs is leaving her post, a senior FDA official confirmed to CBS News, marking the latest high-level shake-up at the FDA.
Dr. Tracy Beth Høeg had served as acting director of the FDA’s Center for Drug Evaluation and Research (CDER) since December, helming an office that reviews applications for new drugs. She previously advised former FDA Commissioner Dr. Marty Makary.
A Health and Human Services spokesperson did not immediately respond to a request for comment. The news of Høeg’s departure was first reported by Reuters.
Høeg is leaving her job three days after Makary resigned as FDA commissioner following a flood of news reports about internal tensions within the agency, including disagreements over a recent decision to approve flavored e-cigarettes. A source familiar with the matter told CBS News that Makary left due to the e-cigarette dispute, adding that the commissioner didn’t want to approve flavored products but had been forced to do so by other members of the administration.
The former head of the FDA office responsible for vaccine approvals, Dr. Vinay Prasad, also departed the agency last month. Prasad briefly left the agency last summer, but was reinstated less than two weeks later.
Høeg’s appointment as the head of CDER had drawn controversy and sparked alarm among senior FDA officials due to her history of vaccine skepticism, CBS News previously reported. She helped write a memo last year linking several children’s deaths to the COVID-19 vaccine, without providing data to back up the claim, and she was involved in a controversial effort to reduce the number of recommended childhood vaccines.
“Putting Tracy Beth in charge is like dropping an atom bomb,” one agency source told CBS News in December.
blob:https://www.cbsnews.com/4085a5d9-bf0d-4a09-b853-318753a92596
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
https://www.cbsnews.com/news/dr-tracy-beth-hoeg-leaving-fda-post-controversy-vaccine-views-makary/
Høeg has acknowledged the effectiveness of some vaccines, including the measles vaccine. She said when she was confirmed that she was “committed to transparency, honesty, and decisions based on rigorous science and ensuring important changes happen efficiently.”
发表回复